FOLH1 and pachyonychia congenita: Whereas short-term ADT seems to increase the uptake at least in some PC lesions [15,16,17,18], the treatment effect of long-term ADT might be accompanied by a lower PSMA ligand uptake and thus, a reduced visibility of tumor lesions [19].